Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2022-07-20 Sale | 2022-07-21 4:09 pm | CytomX Therapeutics Inc. | CTMX | HANNAH ALISON L. Chief Medical Officer | 5,602 | $1.4219 | $7,965 | 31,898 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-08-10 Exercise | 2024-08-13 4:24 pm | 2024-08-10 N/A | NEOGENOMICS INC | NEO | HANNAH ALISON L. Director | 11,336 | $0 | 176,378 (Direct) | View |
| 2024-06-01 Option Award | 2024-06-04 4:07 pm | 2025-06-01 2034-06-01 | NEOGENOMICS INC | NEO | HANNAH ALISON L. Director | 20,926 | $0 | 176,378 (Direct) | View |
| 2024-05-25 Option Award | 2024-05-29 7:20 pm | N/A 2034-05-25 | RIGEL PHARMACEUTICALS INC | RIGL | HANNAH ALISON L. Director | 55,000 | $0 | 111,250 (Direct) | View |
| 2023-08-10 Option Award | 2023-08-14 5:41 pm | 2024-08-10 2033-08-10 | NEOGENOMICS INC | NEO | HANNAH ALISON L. Director | 19,689 | $0 | 155,452 (Direct) | View |
| 2023-05-26 Option Award | 2023-07-12 6:45 pm | N/A 2033-05-26 | RIGEL PHARMACEUTICALS INC | RIGL | HANNAH ALISON L. Director | 55,000 | $0 | 86,250 (Direct) | View |
| 2022-07-19 Option Award | 2022-07-21 4:09 pm | N/A N/A | CytomX Therapeutics Inc. | CTMX | HANNAH ALISON L. Chief Medical Officer | 15,000 | $0 | 31,898 (Direct) | View |
| 2022-06-10 Option Award | 2022-06-14 8:42 pm | 2023-06-10 2029-06-10 | NEOGENOMICS INC | NEO | HANNAH ALISON L. Director | 29,438 | $0 | 135,763 (Direct) | View |
| 2022-05-20 Option Award | 2022-05-23 5:50 pm | N/A 2032-05-20 | RIGEL PHARMACEUTICALS INC | RIGL | HANNAH ALISON L. Director | 55,000 | $0 | 61,250 (Direct) | View |
| 2022-02-02 Option Award | 2022-02-04 4:51 pm | N/A 2032-02-01 | CytomX Therapeutics Inc. | CTMX | HANNAH ALISON L. Chief Medical Officer | 157,500 | $0 | 157,500 (Direct) | View |
| 2021-10-24 Option Award | 2021-10-26 4:24 pm | N/A 2031-10-23 | CytomX Therapeutics Inc. | CTMX | HANNAH ALISON L. Chief Medical Officer | 70,000 | $0 | 70,000 (Direct) | View |
| 2021-06-02 Option Award | 2021-06-04 8:00 pm | 2022-06-02 2028-06-02 | NEOGENOMICS INC | NEO | HANNAH ALISON L. Director | 6,795 | $0 | 106,325 (Direct) | View |
| 2021-05-19 Option Award | 2021-05-21 9:11 pm | N/A 2031-05-19 | RIGEL PHARMACEUTICALS INC | RIGL | HANNAH ALISON L. Director | 13,750 | $0 | 13,750 (Direct) | View |
| 2021-05-14 Option Award | 2021-05-18 7:01 pm | N/A 2031-05-14 | RIGEL PHARMACEUTICALS INC | RIGL | HANNAH ALISON L. Director | 80,000 | $0 | 80,000 (Direct) | View |
| 2021-02-26 Option Award | 2021-03-02 5:00 pm | N/A 2031-02-25 | CytomX Therapeutics Inc. | CTMX | HANNAH ALISON L. Chief Medical Officer | 175,000 | $0 | 175,000 (Direct) | View |
| 2020-08-06 Exercise | 2020-08-10 6:22 pm | N/A 2022-05-25 | NEOGENOMICS INC | NEO | HANNAH ALISON L. Director | 10,000 | $0 | 99,530 (Direct) | View |
| 2020-08-06 Exercise | 2020-08-10 6:22 pm | N/A N/A | NEOGENOMICS INC | NEO | HANNAH ALISON L. Director | 10,000 | $7.27 | 99,530 (Direct) | View |
| 2020-05-28 Option Award | 2020-06-01 7:38 pm | 2021-05-28 2027-05-28 | NEOGENOMICS INC | NEO | HANNAH ALISON L. Director | 6,146 | $0 | 99,530 (Direct) | View |
| 2020-02-03 Option Award | 2020-02-05 3:44 pm | N/A 2030-02-02 | CytomX Therapeutics Inc. | CTMX | HANNAH ALISON L. Chief Medical Officer | 250,000 | $0 | 250,000 (Direct) | View |